See links to the FDA-approved Phase IIa clinical trial of L-serine for ALS patients, and the FDA-approved Phase IIa clinical trial of L-serine for early stage Alzheimer's patients.
L-Serine Safe for ALS Patients
L-serine
We completed a Phase I ALS trial —to demonstrate the safety of the naturally occurring amino acid, L-serine, in humans—that showed encouraging signs of slowing disease progression among enrolled patients.
Read the research here.